TD Waterhouse Canada Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
TD Waterhouse Canada Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,529
-53.5%
2,5310.0%0.00%
Q2 2023$3,290
-24.9%
2,5310.0%0.00%
Q1 2023$4,379
-44.9%
2,5310.0%0.00%
Q4 2022$7,947
-34.2%
2,5310.0%0.00%
Q3 2022$12,073
+11.7%
2,5310.0%0.00%
Q2 2022$10,807
-29.3%
2,5310.0%0.00%
Q1 2022$15,287
-18.6%
2,5310.0%0.00%
Q4 2021$18,7802,5310.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,400,000$12,320,0004.56%
EcoR1 Capital, LLC 2,568,119$22,599,0004.01%
FIC CAPITAL INC 960,338$8,451,0003.48%
Opaleye Management Inc. 580,000$5,104,0002.13%
DAFNA Capital Management LLC 225,000$1,980,0001.41%
RA Capital Management 1,250,000$11,000,0001.26%
Iguana Healthcare Management, LLC 215,000$1,892,0001.07%
Avoro Capital Advisors LLC 800,000$7,040,0000.89%
WASATCH ADVISORS LP 6,930,535$60,989,0000.85%
Cormorant Asset Management, LP 400,000$3,520,0000.58%
View complete list of SANGAMO THERAPEUTICS INC shareholders